Join the Asthma and Allergic Diseases Cooperative Research Centers

Funding News Edition: April 15, 2020
See more articles in this edition

Consider applying for funds to create a new center in the Asthma and Allergic Diseases Cooperative Research Centers (AADCRC) program.

NIAID recently reissued the AADCRC (U19, Clinical Trial Optional) funding opportunity announcement (FOA) in search of single institutions or consortia of institutions to join the AADCRC network or renew existing center grants.

AADCRC-Supported Science

As described in the FOA, the AADCRC awardees integrate innovative, multidisciplinary clinical and translational research to conduct studies on the mechanisms of onset and progression of diseases of interest, including asthma, rhinitis (allergic and non-allergic), chronic rhinosinusitis, atopic dermatitis, food allergy, and drug allergy.

Established almost five decades ago, the NIAID AADCRC program leverages the expertise of center researchers around the United States. Collaborations among participating centers support the overarching goal to better understand the pathogenesis of these conditions and provide a rational foundation for new, effective treatments and prevention strategies.

To learn more about the AADCRC program, including current projects, go to Asthma and Allergic Diseases Cooperative Research Centers.

Plan Your Application

We encourage highly integrated and synergistic research programs, including multi-institutional applications for conditions of interest. We especially encourage research on conditions where research resources are often limited, e.g., non-allergic rhinitis or drug allergy.

Your application must focus on human disease, so your research plans should include clinical trials, human subjects studies, or human materials. 

Describe how your center’s components will coordinate and carry out the broad scope of research delineated in the FOA. Your multiproject AADCRC research program must include an Administrative Core, Service Cores as needed, and at least two Research Projects. The component projects and cores should all relate to one other and be organized around a central theme relevant to the specified diseases of interest.

You could organize your research programs around one of the following approaches:

  • One or more immunologic mechanisms/pathways that are hypothesized to be an important pathobiologic process in a condition of interest to this FOA
  • One or more clinical trials or clinical studies that 1) test a novel therapeutic or preventive approach, or a mechanistic hypothesis, or 2) aim to elucidate disease phenotypes and endotypes in a condition of interest to this FOA

Be sure to check the full list of NIAID programmatic priorities in the FOA. It also lists examples of study types we would not consider responsive.

Details and Deadlines

Awards through this FOA use the multiproject U19 award mechanism. Consider NIAID’s guidance on how to plan and prepare Multiproject Research (P, U) Applications.

Your center budget and project period should reflect the actual needs and scope of your proposal. Request no more than $900,000 in direct costs each year, excluding the infrastructure and opportunity fund budget described in the FOA. Propose no more than five years of support.

Apply by August 28, 2020. Send your optional letter of intent at least 30 days before the application due date.

Direct your application and scientific questions to Dr. Gang Dong, the FOA's scientific/research contact.

Contact Us

Email us at deaweb@niaid.nih.gov for help navigating NIAID’s grant and contract policies and procedures.

Content last reviewed on